drugset / Trial / NCT04302766

Expanded Access Remdesivir (RDV; GS-5734™)

NCT04302766

Expanded access No longer available U.S. Army Medical Research and Development Command

Summary

Disease caused by 2019 Novel Coronavirus also known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

Timeline

Start
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Remdesivir Small molecule

Indications